Gates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement Post author:GHIAA Admin Post published:July 15, 2024 Post category: Continue ReadingGates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement
Gates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement Post author:GHIAA Admin Post published:July 15, 2024 Post category: Continue ReadingGates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
Gates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement Post author:GHIAA Admin Post published:November 9, 2022 Post category: Continue ReadingGates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement
Gates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement Post author:GHIAA Admin Post published:November 8, 2022 Post category: Continue ReadingGates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement
Gates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement Post author:GHIAA Admin Post published:November 8, 2022 Post category: Continue ReadingGates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement